Objective: The aim of the study was to examine the impact of the leucine7 to proline7 (Leu7Pro) polymorphism of the NPY gene on postprandial (PP) lipemia, post-heparin plasma lipoprotein lipase (LPL) and hepatic lipase (HL) activities, and the response of serum lipids to a reduced fat diet. Design and subjects: Seven middle-aged obese subjects with Leu7Pro genotype were matched with seven subjects with Leu7Leu genotype for gender, age, apolipoprotein E phenotype and BMI. These 14 subjects participated in the oral 8 h fat tolerance test. Sixty-eight slightly obese middle-aged subjects (10 with the Leu7Pro genotype) had participated in intervention studies and consumed a reduced fat diet for 8 weeks.
Introduction
Neuropeptide Y (NPY) is a neurotransmitter widely expressed in the central and peripheral nervous systems (Lundberg et al, 1982; Gray & Morley, 1986) . NPY regulates food intake (Stanley & Leibowitz, 1985; Criscione et al, 1998) . In fact, it is the most potent orexigenic neuropeptide and may inhibit leptin-mediated satiety signal pathway with a mechanism so far unknown (Tomaszuk et al, 1996; Palmiter et al, 1998) . Furthermore, NPY-induced overfeeding in rats has been shown to be associated with elevated plasma levels of leptin and insulin (McMinn et al, 1998) . It has been shown in rats that the direct action of NPY on insulin release is inhibitory (Moltz & McDonald, 1985; Vettor et al, 1998) , whereas the central action of NPY indirectly results in an increase in plasma insulin concentration (Moltz & McDonald, 1985) . Based on studies in animal models of obesity and type 2 diabetes, it has been suggested that hyperphagia, reduced energy expenditure and obesity in these animal models may be explained by the hypothalamic resistance of insulin inhibition of NPY neurons (Frankish et al, 1995) . NPY also seems to favor energy storage through increased lipoprotein lipase (LPL) activity in white adipose tissue (Billington et al, 1991 (Billington et al, , 1994 . Regarding dietary factors, long term feeding of high-fat diets has been shown to decrease NPY levels in hypothalamus in rats .
Mature NPY is formed from prepro NPY (96 amino acids), which contains a signal peptide (29 amino acids), a propeptide (31 amino acids), and a mature NPY (36 amino acids). A thymidine(1128)-to-cytosine(1128) polymorphism results in a substitution of leucine (7) by proline in the signal peptide part of prepro NPY. It has been demonstrated that subjects with the proline (Pro) 7 allele in the signal peptide of the NPY gene have higher serum total cholesterol concentrations than subjects with the leucine (Leu) 7 allele . This seems to be particularly true in obese subjects, but there are no explanations for this finding so far . In preschool children the Leu7Pro polymorphism was found to be associated with serum triglyceride (TG) concentration but not the concentrations of serum total or lipoprotein cholesterol . In a recent study the Pro7 allele associated with increased carotid atherosclerosis in elderly nondiabetic subjects and patients with type 2 diabetes (Niskanen et al, 2000) .
Since there is evidence that NPY is associated with LPL activity and insulin concentrations along with the effect of the Leu7Pro polymorphism on fasting serum lipid concentrations, the aim of the present study was to examine the impact of the Leu7Pro polymorphism of the signal peptide of NPY on postprandial lipemia induced by a fat tolerance test as well as on post-heparin plasma activities of LPL and hepatic lipase (HL). Furthermore, the effect of the Leu7Pro polymorphism on the response of serum total and lipoprotein lipids to a reduced fat diet was analyzed in subjects who had previously participated in a diet intervention study with a reduced fat diet period.
Subjects and methods

Subjects
Fourteen subjects participated in the fat tolerance test in which the effect of the Leu7Pro polymorphism on postprandial lipemia was examined. Seven subjects with the Leu7Pro genotype were recruited for the study. They were matched with seven subjects with Leu7Leu genotype for gender, age, apolipoprotein (apo) E phenotype, and body mass index (BMI). The effect of the Leu7Pro polymorphism on the response of serum total and lipoprotein lipids to a reduced fat diet was retrospectively analyzed in 68 subjects who had participated in one of the two diet intervention studies with a reduced fat diet. The results of these two diet intervention studies have been previously presented representing the results of the whole study group (Sarkkinen et al, 1998; Hallikainen & Uusitupa, 1999) . In this report the results of the subjects participating in the reduced fat diet period are presented concentrating strictly on the effect of the NPY polymorphism on the response of serum total or lipoprotein lipids to a reduced fat diet. Ten of the 68 subjects had the Leu7Pro genotype. The inclusion criterion for serum total cholesterol concentration was 5.0 -8.5 mmol=l. The subjects were middle-aged and overweight in both of the studies and all of the subjects had normal liver, kidney and thyroid functions. None of the subjects were on lipid-lowering medication nor were alcohol abusers. The baseline characteristics of the subjects are presented in Table 1 .
All subjects gave their written informed consent and the study plans were approved by the Ethics Committee of the University of Kuopio.
Study design and diets
The subjects who participated in the fat tolerance test did not follow any diet regimen before the test, but a 3-day food record was kept in order to check the possible differences in the diet of the subjects with different NPY genotypes.
In the diet intervention studies the subjects followed a high-fat diet on a 4 week run-in period. The proportions of energy nutrients in this period were 39% of energy (E%) as fat (18 E% saturated, 13 E% monounsaturated, 5 E% polyunsaturated fatty acids). The run-in period was followed by a reduced fat diet period for 8 weeks. The reduced fat diet contained 32 E% as fat (9 E% saturated, 12 E% monounsaturated, 8 E% polyunsaturated fatty acids). These data are based on a 4 day food record kept once during the run-in period and three times during the period with a reduced fat diet.
Oral fat tolerance test
Oral fat tolerance test was performed after a 12 h overnight fast. Subjects were advised to avoid strenuous exercise and not to drink alcohol for 3 days before the test. After fasting blood samples were drawn subjects ate a small rice cake (7.6 g) with a piece of cheese (10 g cheese (fat content 23%)=70 kg body weight). Five minutes after eating the rice cake subjects drank a cream mixture of standard dairy cream (38% fat) and a cream-like dairy product with fat of vegetable origin (20% fat; Van den Bergh Foods, Helsinki, Finland) . The amount of fat load was 33 g=m 2 body surface. Blood samples were drawn at 0.5, 1, 2, 3, 4, 6, and 8 h after the test meal.
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Heparin test
A 15 min heparin test was performed after a 12 h overnight fast to measure LPL and HL activity released by heparin. Subjects were given 100 IU=kg body weight of non-fractionated heparin (Lövens, Denmark) through an intravenous catheter in an antecubital vein after a basal (0 min) sample. A 15 min sample was drawn in the antecubital vein of the contralateral arm.
Laboratory measurements
The lipid classes were separated as previously described (Å gren et al, 1998) . In brief, to separate chylomicrons, 1.8 ml of plasma was overlaid with 1.6 ml of NaCl solution (d ¼ 1.006 g=ml) with Titriplex III (Merck, Darmstadt, Germany) and ultracentrifuged with a Beckman 50.2 Ti rotor (Beckman Instruments, Palo Alto, CA) in a Beckman Optima L-90K ultracentrifuge (Palo Alto, CA; 16 C, 18 000 rpm, 30 min). The top 1 ml was aspirated. To separate VLDL, the chylomicron free infranate was overlaid with 900 ml of the previously mentioned NaCl solution and ultracentrifuged with a Beckman 50.2 Ti rotor at 16 C and 37 000 rpm for 15 h. The top 1 ml was aspirated. Part of the rest of the sample was precipitated with dextran sulfate and magnesium chloride to precipitate LDL (Penttilä et al, 1981) . The cholesterol and TG concentrations of the other part was analyzed to represent the concentration of LDL þ HDL in the sample. Enzymatic colorimetric methods (Monotest Cholesterol and Triglyceride GPO-PAP; Boehringer, Mannheim, Germany) were used to analyze the cholesterol and TG concentrations of the samples. Concentration of serum total and lipoprotein lipids in fasting samples was determined using the same method. The interassay and intra-assay CV were 1.3 and 1.6%, respectively, for cholesterol, and 5.2 and 1.7%, respectively, for TG.
Enzymatic colorimetric method was used for quantification of serum free fatty acids (FFA). A WAKO NEFA C test kit (Wako Chemicals GmbH, Neuss, Germany) was used with Kone Specific Clinical Analyzer (Kone Instruments, Espoo, Finland).
The Leu7Pro polymorphism of the NPY gene was determined as previously described by digesting the samples by the BsiEI (New England Biolabs, Beverly, MA), since the thymidine(1128)-to-cytosine(1128) substitution in NPY generates a new BsiEI restriction site. The digestions were analyzed by electrophoresis on 2% agarose gel. The apolipoprotein (apo) E phenotype was determined from plasma after delipidation, using isoelectric focusing and immunoblotting techniques Menzel & Utermann, 1986) .
The TG-hydrolyzing activity of HL was measured in the presence of 1 mol=l NaCl using triolein as substrate . The substrate was emulsified with 1% gum arabic in 0.2 mmol=l Tris -HCl buffer, pH 8.5. Plasma total TG hydrolyzing activity was measured as described by , but in the presence of 0.15 mmol=l NaCl and 10% normal human serum. LPL activity was determined by subtracting HL activity from total activity. One subject of those with the Leu7Leu genotype did not participate in the heparin test.
Plasma glucose concentration was analyzed using the glucose oxidase method (Glucose Auto & Stat, model GA-110, Daiici, Kyoto, Japan) with a Kone Pro instrument (Kone Instruments, Espoo, Finland). The intra-assay and interassay CV were 1.4% and 2.7 -3.8%, respectively. Plasma insulin concentration was analyzed using a radioimmunoassay method (Phadeseph Insulin RIA 100, Pharmacia Diagnostics, Uppsala, Sweden) and the interassay CV was 4.2 -5.6%.
Statistical analyses
The data were analyzed with the SPSS=PC þ statistics program (V 8.0, SPSS, Chicago, IL). Mann -Whitney test was used for the comparison of the groups, and Pearson's correlation coefficient was used for correlation analyses. In analyzing the results of the fat tolerance test area under the curve (AUC) was calculated using a Canvas software (V 6.0, Deneba systems, Inc., Miami, FL) as a curve above the baseline and presented as mmol=l Á h. The data are expressed as mean AE s.e.m.
Results
Clinical characteristics
There were no significant differences in age or BMI between the subjects with the Leu7Leu and Leu7Pro genotypes (Table Leu7Pro in NPY gene and lipid response US Schwab et al 1). Regarding serum total and lipoprotein lipids, concentrations of serum total and VLDL cholesterol and total TG were significantly higher in subjects with the Leu7Pro genotype than in subjects with the Leu7Leu genotype among subjects participating in the fat tolerance test (Table 1) . No differences in these variables were found among subjects who had participated in the diet intervention study with a reduced fat diet.
Dietary data
On the basis of 3 day food records kept by the subjects participating in the oral fat tolerance test, no difference in the intake of energy, energy nutrients or dietary cholesterol or fiber was found (data not shown). Neither was there any difference in the compliance to the reduced fat diet in the intervention studies among subjects with different NPY genotypes ( Table 2) .
Postprandial lipemia and lipase activities by NPY genotype Postprandial lipemic responses are shown in Figure 1 and the AUC in the fat tolerance tests are presented in Table 3 . There were no statistically significant differences in responses of plasma concentrations of total TG, total chylomicrons, chylomicron TG, VLDL TG, HDL TG (Figure 1 ) or the corresponding fractions of plasma cholesterol between the two groups. Neither were there any difference in plasma FFA or insulin responses to the oral fat load (Figure 1 ). The AUC for plasma insulin was 204.0 AE 55.8 pmol=l Á h in subjects with the Leu7Leu genotype and 219.0 AE 78.0 pmol=l Á h in subjects with the Leu7Pro genotype.
To further explore the postprandial lipid metabolism the TG-to-cholesterol ratio in VLDL was calculated (Figure 2 ). The ratio was significantly (P < 0.05) smaller in the subjects with the Leu7Pro genotype compared to the subjects with the Leu7Leu genotype at time points 30 min and 1 h. Furthermore, in the subjects with the Leu7Pro genotype the ratio was lower at 8 h than the fasting level, whereas in the subjects with the Leu7Leu genotype the ratio remained above the fasting level during the whole 8 h follow-up period. The fasting concentration of plasma and VLDL TG correlated significantly with the AUC of VLDL TG in the subjects with the Leu7Leu genotype (r ¼ 0.77, P ¼ 0.043 and r ¼ 0.80, P ¼ 0.030, respectively) but not in the subjects with the Leu7Pro genotype (r ¼ 7 0.06 and r ¼ 0.14, P ¼ NS). Furthermore, the AUC of chylomicrons correlated significantly with the AUC of VLDL TG in the subjects with the Leu7Leu genotype (r ¼ 0.93, P ¼ 0.002), but not in the subjects with the Leu7Pro genotype (r ¼ 0.04, P ¼ NS).
Analysis of the heparin-releasable lipases revealed no differences in LPL activity between the groups (20.9 AE 1.2 vs 20.0 AE 1.2 mmol=1 h, Leu7Leu genotype vs Leu7Pro genotype, respectively). HL activity tended to display higher levels in subjects with the Leu7Leu genotype compared to that of the subjects with the Leu7Pro genotype without reaching statistical significance (42.7 AE 4.2 vs 33.6 AE 3.6 mmol=l Á h, respectively, P ¼ 0.132). The HL-to-LPL ratio correlated significantly with the fasting VLDL TG concentration (r ¼ 0.84, P ¼ 0.037) and the AUCs of TG (r ¼ 0.93, P ¼ 0.008), VLDL TG (r ¼ 0.99, P < 0.0001) and chylomicron TG (r ¼ 0.93, P ¼ 0.008) in the subjects with the Leu7Leu genotype but not in the subjects with the Leu7Pro genotype (r ¼ 0.54, r ¼ 0.02, r ¼ 7 0.17, and r ¼ 0.07, respectively; Figure 3 ).
Responses of serum lipids to a reduced fat diet by NPY genotype
The mean change in serum total and LDL cholesterol concentrations on a reduced fat diet was 7 9.0 AE 1.3 and 711.2 AE 2.0%, respectively, in subjects with the Leu7Leu genotype and 7 7.9 AE 1.8 and 7 8.9 AE 2.4%, respectively, in subjects with the Leu7Pro genotype. However, these differences did not reach statistical significance between the two groups. Neither were there any differences between the groups in the response of the concentrations of serum total TG, HDL cholesterol or VLDL cholesterol to a reduced fat diet (Table 4) .
Discussion
It was recently demonstrated that the Leu7Pro polymorphism of the NPY gene is linked to lipid metabolism: obese subjects with the Pro7 allele have higher serum total and LDL cholesterol concentrations than subjects with the Leu7 allele . Elevated serum total and LDL cholesterol concentrations in obese subjects with the Pro7 allele could be ascribed to an increase in cholesterol absorption or endogenous biosynthesis. However, disturbed liver uptake or catabolism of LDL could also play a role. NPY has been suggested to regulate LPL activity in adipose tissue of experimental animals (Billington et al, 1991 (Billington et al, , 1994 . This Table 2 Energy intake, proportion of energy nutrients, and the intake of dietary cholesterol and fiber during the run-in period and the reduced fat diet period, mean AE s.e.m. . Figure 1 Responses of plasma total, chylomicron, VLDL and HDL triglycerides, and serum free fatty acids and plasma insulin to an oral fat tolerance test in subjects with the Leu7Leu genotype and subjects with the Leu7Pro genotype of the NPY gene. Mean AE s.e.m., n ¼ 7 in both groups.
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Several factors have been shown to affect postprandial lipemia. These include age, gender, BMI, apoE genotype, intestinal fatty acid binding protein 2 (I-FABP2) polymorphism and fasting serum=plasma TG and insulin concentrations (Å gren et al, 1998; Cohn et al, 1988; Roche & Gibney, 1995) . The balance between hepatic uptake of lipoproteins and bile acid biosynthesis and excretion also clearly affects plasma lipid concentrations in the fasted and fed state (Dietschy et al, 1993; Dueland et al, 1997) . In the present study with the oral fat tolerance test, the subjects were matched for age, gender, BMI and apoE phenotype. Furthermore, fasting plasma insulin concentrations were similar in the groups. However, fasting plasma TG and cholesterol concentrations were significantly higher in subjects with the Leu7Pro genotype compared to the subjects with the Leu7Leu genotype.
No statistically significant differences were found in postprandial lipid responses (AUC) between the subjects with the Leu7Leu genotype compared to the subjects with the Leu7Pro genotype. The postprandial plasma lipid levels, especially total TG, of the subjects with the Leu7Pro genotype tended to be at higher levels than that of the subjects with the Leu7Leu genotype. However, the fasting plasma TG level in the subjects with the Pro7 allele was so high that the Figure 2 The triglyceride-to-cholesterol ratio in VLDL at each time point of the oral fat tolerance test. Mean AE s.e.m., n ¼ 7 in both groups. *P < 0.05 between the genotype groups. Figure 3 Correlations of the hepatic lipase-to-lipoprotein lipase (HL-to-LPL) ratio with the area under the curve (AUC) of TG, VLDL TG, and chylomicron TG. n ¼ 6 in the Leu7Leu group and n ¼ 7 in the Leu7Pro group.
Leu7Pro in NPY gene and lipid response US Schwab et al postprandial increase in plasma TG concentration might have been expected to be even higher than the actual observed response. In a closer analysis it was found that the TG-to-cholesterol ratio in VLDL was higher in the subjects with the Leu7Leu genotype compared to the subjects with the Leu7Pro genotype. The TG-to-cholesterol ratio also remained above the baseline level throughout the 8 h fat tolerance test in the subjects with the Leu7Leu genotype whereas in the subjects with the Pro7 allele the 8 h value was lower than the fasting value. An explanation for this finding could be that the particles of the subjects with the Leu7Leu genotype are of a different nature as substrates for LPL than the particles of the subjects with the Leu7Pro genotype. It is noteworthy that the concentration of FFAs was somewhat higher and the concentration of plasma TG was somewhat lower in the fat tolerance test in the subjects with the Leu7Leu genotype compared to the subjects with the Pro allele. It might also be speculated that there is a difference in the density of VLDL between the subjects with different NPY genotypes. More dense VLDL 2 seems to be less affected by fat intake than TG-rich VLDL 1 , which competes with chylomicrons for hydrolysis of TG (Björkegren et al, 1997) . Since the subjects with Pro7 allele had lower response than expected and lower fasting and postprandial TG-to-cholesterol ratio, it is reasonable to think that the subjects with Pro7 allele may have a higher proportion of VLDL 2 than the subjects with the Leu7Leu genotype. Furthermore, the finding that fasting plasma total and VLDL TG concentration correlated with the AUC of VLDL TG only in the subjects with the Leu7Leu genotype supports the idea of compositional differences in the VLDL in the subjects with different NPY genotypes.
It has been suggested that centrally administered NPY increases the expression of LPL mRNA and enhances LPL activity in white adipose tissue thus favoring lipid storage (Billington et al, 1991 (Billington et al, , 1994 . In the present study, the heparin-releasable LPL activity did not differ among the genotype groups. Regarding the heparin-releasable HL activity there was a tendency towards higher activities in the subjects with the Leu7Leu genotype compared to the subjects with the Leu7Pro genotype. The HL-to-LPL ratio correlated significantly with the area of plasma total, VLDL and chylomicron TG in the subjects with the Leu7Leu genotype whereas such correlation was missing in subjects with the Pro7 allele. Further studies are warranted to clarify the effect of Leu7Pro polymorphism on LPL and HL activities.
In experimental animals NPY has been shown to be associated with insulin metabolism (Moltz & McDonald, 1985; Vettor et al, 1998) . In the present study, no difference in either fasting insulin concentration or postprandial insulin response was found between the genotype groups.
There was no significant difference in the fasting serum total or LDL cholesterol concentrations between the genotype groups in the intervention studies. Neither was there any difference in the response of serum lipids to a reduced fat diet. The results regarding fasting serum lipid concentrations differed from the results of the subjects participating in the oral fat tolerance test. The possible explanation for this discrepancy may be the BMI. The mean BMI was 26 kg=m 2 among the subjects who participated in the intervention studies, but was much higher (34 -35 kg=m 2 ) among the subjects who participated in the oral fat tolerance test. In the study by Karvonen et al (1998) , the association of the Pro7 allele with serum total and LDL cholesterol concentrations was more pronounced in obese subjects (BMI ! 30) than in subjects with normal body weight (BMI 24 -25 kg=m 2 ). Similar responses of the subjects with different genotypes to a reduced fat diet indicate that elevated serum total and LDL cholesterol concentrations in the subjects with the Pro7 allele could not be attributed to differences in diet response. The response to a reduced fat diet should be studied further in markedly obese subjects with a difference in the fasting serum lipid concentrations since the effect of Leu7Pro polymorphism in NPY gene seems to be more prominent in obese subjects.
The replacement of Leu by Pro in the signal peptide part of preproNPY may disturb the kinetics of NPY, since the structure of these two amino acids is very different. Introducing a proline to an amino acid sequence of a protein most often causes a turn-point and thus a major conformational change and possibly could modulate the cleavage process of signal peptide during the biosynthesis of NPY. However, the mechanisms behind higher serum total and LDL cholesterol concentrations in subjects with the Pro7 allele, in particular in obese subjects, remain unknown and more comprehensive studies on cholesterol kinetics between the subjects with the Leu7Leu and Leu7Pro genotypes are needed. Leu7Pro in NPY gene and lipid response US Schwab et al
In conclusion, there is no significant difference in the magnitude of postprandial lipemia induced by an oral fat tolerance test between obese subjects with the Leu7Pro genotype compared to those with the Leu7Leu genotype. However, the results of this preliminary study suggest that there might be compositional differences in the lipid particles, especially in TG-rich lipoproteins, between the genotype groups possibly affecting postprandial lipid metabolism. Furthermore, the relationship of LPL and HL activities to lipid metabolism may also differ between the genotype groups. There was no difference in the response to a reduced fat diet between the genotype groups among slightly obese subjects. However, this does not rule out the possible difference in response to dietary fat modification in markedly obese subjects. Therefore further studies are required to delineate in more detail the role of Leu7Pro polymorphism of the NPY gene in postprandial lipemia and lipolytic processes.
